日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Innovation

Hong Kong scientists discover deadly brain cancer mutation route

Xinhua | Updated: 2018-12-03 22:24
Share
Share - WeChat

HONG KONG -- The mutational mechanism of a rare and deadly brain cancer has been uncovered by scientists from the Hong Kong University of Science and Technology, providing new therapeutic lead to the disease.

Starting off at nerve cells around the spine and brain, lower-grade glioma (LGG) is the early form of sGBM -- one of the deadliest brain cancers. While sGBM can be treated with surgery or an oral chemotherapy drug, most of these malign tumors would mutate and return with mortality rate reaching almost 100 percent.

In their latest study made public on Monday, the team led by Wang Jiguang, assistant professor at the university's Division of Life Science and Department of Chemical and Biological Engineering, analyzed and integrated the genomic data of 188 sGBM patients, including newly collected samples from Chinese mainland and South Korean patients.

The study found that about 14 percent of the sampled sGBM patients displayed mutations in this gene.

Taking reference from this discovery, the university's collaborators, Jiang Tao and his team from Beijing Neurosurgical Institute and Beijing Tiantan Hospital, identified a drug molecule named PLB-1001 that can reach the tumors in the brain.

The molecule shows remarkable potency in selectively targeting sGBM tumors and those displaying further gene mutations.

The clinical trial of PLB-1001 on 18 recurrent patients at late cancer stage returned with a partial positive response in two patients.

After being prescribed a daily dosage ranging from 50 to 300 mg at Beijing Tiantan Hospital, the two patients experienced significant tumor shrinkage, with relieved symptoms and little side effects, lasting for more than 12 weeks.

The outcome of this clinical trial is significant in a sense that it furthers the knowledge about sGBM treatment, Wang said, adding that developing computational models on cancer evolution helps predict cancer cells' future behavior and prioritize treatment options.

Wang said more studies on PLB-1001 are needed to see if it can be used in conjunction with other drugs in achieving more persistent results.

The findings were published in scientific journal Cell on Nov 29.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 欧美经典成人在观看线视频 | 插插插天天| 亚洲AV久久综合无码东京 | 亚州综合网 | 毛片卡一卡二 | 八武将免费完整版在线观看 | 国产欧美精品亚洲桃花岛 | 欧美视频亚洲视频 | 欧美久操 | 亚洲九九香蕉 | 欧美大片在线看免费观看 | 人人天天操 | 2022国内精品免费福利视频 | 一级a毛片 | 91精品中文字幕一区二区三区 | 日本夜爽爽一区二区三区 | 天天综合亚洲 | 日日夜夜天天人人 | 一本一道久久综合狠狠老 | 亚洲成人福利在线观看 | 69午夜| 黄色入口网站 | 免费的黄色一级片 | 一区二区三区亚洲 | 黄色视频a级毛片 | 波多野结衣中文在线播放 | 五月天激情视频 | 香蕉国产成版人视频在线观看 | 久久国产热视频 | 超碰人操| 黄色av毛片 | 亚洲精品www| 大伊香蕉在线观看视频 wap | 日本一区二区三区四区 | 亚洲欧美18v中文字幕高清 | 国产精品福利视频免费观看 | www.人人干 | 91 在线观看 | 小视频在线观看免费 | 一区二区三区四区国产 | 天天天天做夜夜夜夜 |